Kezar Life Sciences Inc (KZR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 7,365 | 15,164 | 11,715 | 14,599 | 17,629 |
| Operating Income | -7,365 | -15,164 | -11,715 | -14,599 | -17,629 |
| Interest Expense | 0 | 0 | 0 | 302 | 347 |
| Other Income | 1,609 | 618 | 488 | 1,197 | 1,420 |
| Pre-tax Income | -5,756 | -14,546 | -11,227 | -13,704 | -16,556 |
| Net Income Continuous | -5,756 | -14,546 | -11,227 | -13,704 | -16,556 |
| Net Income | $-5,756 | $-14,546 | $-11,227 | $-13,704 | $-16,556 |
| EPS Basic Total Ops | -0.78 | -1.99 | -1.53 | -1.87 | -2.27 |
| EPS Basic Continuous Ops | -0.78 | -1.98 | -1.53 | -1.87 | -2.27 |
| EPS Diluted Total Ops | -0.78 | -1.99 | -1.53 | -1.87 | -2.27 |
| EPS Diluted Continuous Ops | -0.78 | -1.98 | -1.53 | -1.87 | -2.27 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.99 | -1.53 | -1.87 | -2.27 |
| EBITDA(a) | $-7,318 | $-15,283 | $-11,945 | $-14,901 | $-17,907 |